Skip to main content

Table 6 Top three pathways containing most unique biomarkers, as well as which biomarkers were not covered by the top three pathways (however were part of a PWM)

From: Extending inherited metabolic disorder diagnostics with biomarker interaction visualizations

HGNC Name Disorder

Patient Label; diagnosis possible?

(Yes, No, Direction)

Pathways in Top 3 (WikiPathways ID)

[amount of covered biomarkers]*

Not covered biomarkers (ChEBI IDs; corresponding names)

UPB1D

J

No

Pyrimidine metabolism and related diseases (WP4225) [5]

Amino acid metabolism (WP3925)# [3]

Purine metabolism (WP4792) [3]

4 (16283 18019 27596 30913; Cystine, Lysine, 3-Methyl-histidine, Pipecolic acid)

DPYD

A

Yes

Amino acid metabolism (WP3925) [6]

Biomarkers for pyrimidine metabolism disorders (WP4584) [5]

Urea cycle and related diseases (WP4571)# [1]

4 (17,553 18237 7274 15727; Phosphoethanolamine, Glutamic acid, Formiminoglutamic acid, Carnosine)

E

Direction

Amino acid metabolism (WP3925) [5]

Pyrimidine metabolism and related diseases (WP4225) [3]

4 (18237 35621 86498 16000; Glutamic acid, AABA, Hydroxylysine, Monoethanolamine)

I

Yes

Biomarkers for pyrimidine metabolism disorders (WP4584) [4]

Purine metabolism (WP4792) [1]

2 (17261 70744; N-Aspartylglucosamine, Gly-pro)

K

Yes

Biomarkers for pyrimidine metabolism disorders (WP4584) [3]

Urea cycle and related diseases (WP4571) [1]

1 (18237; Glutamic acid)

ASL

F

Yes

Biomarkers for urea cycle disorders (WP4583) [4]

One-carbon metabolism and related pathways (WP3940) [3]

Pyrimidine metabolism (WP4002) [1]

4 (86498 15727 27596 85981; Hydroxylysine, Carnosine, 3-Methyl-histidine, Homocarnosine)

L

Yes

Urea cycle and related diseases (WP4571) [4]

Glycerophospholipid biosynthetic pathway (WP2533) [2]

Amino acid metabolism (WP3925) [2]

7 (18237 27596 85981 16283 17549 17261 17368; Glutamic acid, 3-Methyl-histidine, Homocarnosine, Cystine, Aminolevulinic acid, N-Aspartylglucosamine, Hypoxanthine)

M

Yes

Amino acid metabolism (WP3925) [14]

Urea cycle and associated pathways (WP4595) [7]

9 (85981 15727 17261 16283 27596 18237 16000 18019 16865; Homocarnosine, Carnosine, N-Aspartylglucosamine, Cystine, 3-Methyl-histidine, Glutamic acid, Monoethanolamine, Lysine, GABA)

N

Yes

Amino acid metabolism (WP3925) [15]

Urea cycle and associated pathways (WP4595) [7]

14 (17553 18237 85981 27596 15727 16865 17261 16000 37024 58148 18019 15611 27891 16283; Phosphoethanolamine, Glutamic acid, Homocarnosine, 3-Methyl-histidine, Carnosine, GABA, N-Aspartylglucosamine, Monoethanolamine, 2-Aminoadipic acid, Homocitrulline, Lysine, Sarcosine, S-sulfocysteine, Cystine)

T

Yes

Amino acid metabolism (WP3925) [12]

Urea cycle and associated pathways (WP4595) [6]

Vitamin B6-dependent and responsive disorders (WP4228) [3]

11 (16000 27596 85981 17553 17261 18237 16283 17549 16865 16811 86498; Monoethanolamine, 3-Methyl-histidine, Homocarnosine, Phosphoethanolamine, N-Aspartylglucosamine, Glutamic acid, Cystine, Aminolevulinic acid, GABA, Methionine, Hydroxylysine)

ASS1

D

Yes

Amino acid metabolism (WP3925) [7]

Pyrimidine metabolism and related diseases (WP4225) [5]

Vitamin B6-dependent and responsive disorders (WP4228) [2]

3 (49015 7274 32682; Piperideine carboxylic acid, Formiminoglutamic acid, Arginine)

SLC25A15

H

No

Amino acid metabolism (WP3925) [16]

Pyrimidine metabolism and related diseases (WP4225) [8]

Biomarkers for urea cycle disorders (WP4583)# [3]

21 (18019 27596 15611 16000 18323 18237 35621 37024 16283 86498 16865 15727 85981 16927 17261 17549 27891 70744 50599 7274 17553; Lysine, 3-Methyl-histidine, Sarcosine, Monoethanolamine, Anserine, Glutamic acid, AABA, 2-Aminoadipic acid, Cystine, Hydroxylysine, GABA, Carnosine, Homocarnosine, Saccharopine, N-Aspartylglucosamine, Aminolevulinic acid, S-sulfocysteine, Gly-pro, 1-Methyl-histidine, Formiminoglutamic acid, Phosphoethanolamine)

OTC

G

Direction

Pyrimidine metabolism and related diseases (WP4225) [8]

Alanine and aspartate metabolism (WP106) [2]

Purine metabolism (WP4792) [2]

7 (35621 58148 27596 37024 7274 16000 16414; AABA, Homocitrulline, 3-Methyl-histidine, 2-Aminoadipic acid, Formiminoglutamic acid, Monoethanolamine, Valine)

O

No

Amino acid metabolism (WP3925) [15]

Biomarkers for urea cycle disorders (WP4583) [7]

One-carbon metabolism and related pathways (WP3940) [4]

16 (18323 27891 50599 86498 27596 35621 18019 37024 15727 18237 16283 17261 7274 16865 85981 17568; Anserine, S-sulfocysteine, 1-Methyl-histidine, Hydroxylysine, 3-Methyl-histidine, AABA, Lysine, 2-Aminoadipic acid, Carnosine, Glutamic acid, Cystine, N-Aspartylglucosamine, Formiminoglutamic acid, GABA, Homocarnosine, Uracil)

R

Direction

Amino acid metabolism (WP3925) [16]

Pyrimidine metabolism and related diseases (WP4225) [7]

Biomarkers for urea cycle disorders (WP4583) [3]

17 (17553 16000 18019 15727 16865 27596 18237 16283 16811 17261 86498 85981 27891 17549 35621 15611 37024; Phosphoethanolamine, Monoethanolamine, Lysine, Carnosine, GABA, 3-Methyl-histidine, Glutamic acid, Cystine, Methionine, N-Aspartylglucosamine, Hydroxylysine, Homocarnosine, S-sulfocysteine, Aminolevulinic acid, AABA, Sarcosine, 2-Aminoadipic acid)

S

Direction

Amino acid metabolism (WP3925) [15]

Pyrimidine metabolism and related diseases (WP4225) [6]

Glycerolipids and glycerophospholipids (WP4722)# [2]

13 (85981 15727 16811 27596 16865 18019 16283 57472 86498 17261 18237 35621 17549; Homocarnosine, Carnosine, Methionine, 3-Methyl-histidine, GABA, Lysine, Cystine, Argininosuccinate, Hydroxylysine, N-Aspartylglucosamine, Glutamic acid, AABA, Aminolevulinic acid)

  1. # indicates different pathways cover the same amount of unique metabolites leading to a manual selection of the most relevant pathway
  2. * : – indicates no third pathway was selected